Next-Generation Sequencing scans for entire candidate genes influencing clinical outcomes, allowing the detection of deletions, duplications, and over 97% of CFTR mutations associated with CF, thereby expanding the number of variants with unknown clinical significance. This evidence concerns the gene CFTR and cystic fibrosis.